RNAZ
#4898
TransCode Therapeutics, Inc. - Common Stock
8.1 4 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.55%
Monthly Change
+58.37%
6 month change
-14.39%
Year Change
-14.39%
Previous Close
8.4 4
Open
7.7 6
Low
7.7 6
High
8.1 4
Volume
5
Financials
- Market Capitalization 7.74 M
- Employee 12
- Founded 2016
- CEO N/A
- Website www.transcodetherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00ZGYHV03
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.32
Price to sales ratio
-68.24
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4885 |  MTVA MetaVia Inc. - Common Stock | 1.57 USD | -0.63% | +6.80% | -13.74% | +141.54% | 8.11 M USD | ||
| 4897 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 4.03 USD | -0.49% | +3.07% | -16.04% | -33.83% | 7.74 M USD | ||
| 4899 |  PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.72 USD | +1.41% | -4.00% | +1.41% | -33.94% | 7.73 M USD | ||
| 4900 |  ELOX Eloxx Pharmaceuticals, Inc. | 11.20 USD | +2.28% | -5.88% | +12.00% | +12.00% | 7.71 M USD |
Frequently asked questions about TransCode Therapeutics, Inc. - Common Stock
What is the TransCode Therapeutics, Inc. - Common Stock stock price today?
The current price of TransCode Therapeutics, Inc. - Common Stock (RNAZ) is 8.14. Over the past 24 hours, the stock has changed by -3.55%. Follow the RNAZ chart for real-time price dynamics.
What is the stock ticker of TransCode Therapeutics, Inc. - Common Stock?
TransCode Therapeutics, Inc. - Common Stock trades under the ticker RNAZ. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is TransCode Therapeutics, Inc. - Common Stock stock going up?
RNAZ has changed by +15.63% over the last week, +58.37% over the last month, and -14.39% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was TransCode Therapeutics, Inc. - Common Stock net income for the last quarter?
TransCode Therapeutics, Inc. - Common Stock reported net income of -17.79 M for the last quarter. The previous quarter showed -13.44 M, which means net income changed by -32.30%.
How many employees does TransCode Therapeutics, Inc. - Common Stock have?
As of the latest available data, TransCode Therapeutics, Inc. - Common Stock has 12 employees. Workforce size can provide additional context about the company's scale and operations.
What is TransCode Therapeutics, Inc. - Common Stock EBITDA?
TransCode Therapeutics, Inc. - Common Stock EBITDA is -17.75 M, and its EBITDA margin is 84.1 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy TransCode Therapeutics, Inc. - Common Stock stock?
You can buy TransCode Therapeutics, Inc. - Common Stock (RNAZ) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in TransCode Therapeutics, Inc. - Common Stock stock?
Investing in TransCode Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNAZ chart and related analysis on metatrader.com as part of your research.